Table 1  Demographic and clinical characteristics of subjects.

From: Elevation of plasma tRNA fragments as a promising biomarker for liver fibrosis in nonalcoholic fatty liver disease

Factor

NAFLD (N = 114)

Control (N = 42)

p-value

Demographics

Female patients

84 (73.7%)

30 (71.4%)

0.1622†

Age (year)

46 ± 2.73

45.16 ± 2.75

0.8292‡

BMI (kg/m2)

25.08 ± 0.56

22.78 ± 0.6194

0.0093‡

Biochemical profile

ALT (IU/L)

65.47 ± 25.97

44.42 ± 14.71

0.4851‡

AST (IU/L)

63.89 ± 23.87

25.74 ± 3.11

0.1217‡

GGT (U/L)

128.2 ± 52.47

66.33 ± 26.9

0.3284‡

ALP (U/L)

113 ± 15.31

98.77 ± 12.67

0.4844‡

TBil (μmol/L)

13.8 ± 1.988

15.58 ± 2.923

0.6168‡

DBil (μmol/L)

5.284 ± 1.37

6.074 ± 1.74

0.7236‡

FBG (mmpl/L)

5.044 ± 0.2014

4.705 ± 0.1465

0.1825‡

HDL (mmpl/L)

1.15 ± 0.1046

1.33 ± 0.1848

0.4108‡

LDL (mmpl/L)

3.445 ± 0.2972

2.22 ± 0.2414

0.0362‡

TG (mmpl/L)

2.201 ± 0.3749

1.309 ± 0.2462

0.0239‡

TC (mmpl/L)

5.4 ± 0.347

4.411 ± 0.2408

0.0178‡

  1. Values presented as mean ± standard deviation or N (column %).
  2. BMI body mass index, ALT alanine aminotransferase, AST aspartate aminotransferase, GGT gamma-glutamyl transferase, ALP alkaline phosphatase, Tbil total bilirubin, Dbil direct bilirubin, FBG fasting blood glucose, HDL high-density lipoprotein, LDL low-density lipoprotein, TG triglycerides, TC total cholesterol, NAFLD non-alcoholic fatty liver disease.
  3. p-values: †Pearson’s chi-squared test, ‡Student's t‐test.
Back to article page